| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 01/03/2007 | CN1293134C Phosphor-contained fire-retardant with two spirane structure and preparation method |
| 01/03/2007 | CN1293085C Process for the production of pentaerythritol phosphate alcohol |
| 01/03/2007 | CN1293084C Process for synthesizing liquid crystal compound by catalytic cross-coupling of diphenyl-phosphino- palladium acetate |
| 01/02/2007 | US7157448 Acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 01/02/2007 | US7157092 3-(3-dodecanoyloxytetradecanoylamino) 9-(3-hydroxytetradecanoylamino)-4-oxo-5-azadecan-1,10-diol, 1,10-bis-(dihydrogenphosphate) or its addition salts; treatment of diseases related to a deficiency in the immune defense system or an overexpression of immune responses, cancer therapy |
| 01/02/2007 | CA2275451C Radioactive technetium and rhenium nitride heterocomplexes |
| 01/02/2007 | CA2191454C Phosphinic acid derivatives and their use as endothelin converting enzyme inhibitors |
| 12/28/2006 | WO2006137953A1 Phosphono-pent-2-en-1-yl nucleosides and analogs |
| 12/28/2006 | WO2006136695A2 Novel p-chiral functionalised arylphosphines and derivatives, the preparation and use thereof for asymmetrical catalysis |
| 12/28/2006 | WO2006136564A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 12/28/2006 | WO2006136442A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | WO2005080587A3 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation |
| 12/28/2006 | US20060293534 Contacting a fluoropolyether or fluoroalkyl primary bromide or iodide, with triaryl phosphine, triaryl arsine, or triaryl stibine or triaryl phosphine oxide, triaryl arsine oxide or triaryl stibine oxide, contacting oxide product with a reducing agent to form substituted aryl phosphine, arsine or stibene |
| 12/28/2006 | US20060293524 Process for preparation of bisphosphonic acid compounds |
| 12/28/2006 | US20060293473 Vanadium complexes of phosphino- or arsino-substituted alcohols; homo- and copolymerization of olefins; activators, promoters, supports |
| 12/28/2006 | US20060293344 Viricide against herpes virus; a pyrazolo[1,5- alpha]pyridinyl compounds; chemical synthesis |
| 12/28/2006 | US20060293286 Resistant-repellent retroviral protease inhibitors |
| 12/28/2006 | US20060293285 Aryl Phosphate Derivatives of d4T |
| 12/28/2006 | US20060293284 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 12/28/2006 | US20060293283 Prodrugs of A2B adenosine receptor antagonists |
| 12/28/2006 | US20060293274 Cancer therapy |
| 12/28/2006 | US20060293271 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 12/28/2006 | US20060293268 Antisense antiviral compounds and methods for treating foot and mouth disease |
| 12/28/2006 | US20060292691 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 12/28/2006 | US20060292589 Oligonucleotide probes containing two labels useful in hybridization assays |
| 12/28/2006 | DE19681298B4 Flammhemmende Harzzusammensetzung und Verfahren zur Herstellung einer organischen Phosphorverbindung A flame-retardant resin composition and process for production of an organic phosphorus compound |
| 12/28/2006 | DE102005030400A1 Verfahren zur Herstellung von Arylaminen, Arylethern und Arylthioethern Process for the preparation of aryl amines, aryl ethers and aryl thioethers |
| 12/28/2006 | CA2610742A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/27/2006 | EP1736467A1 Novel sulfonamide derivative |
| 12/27/2006 | EP1735324A1 Preparation of p-chirogenic phospholanes and their use in asymetric synthesis |
| 12/27/2006 | EP1735323A1 Synthetic membrane anchors |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1507783B1 Hydroxy diphosphines and their use in catalysis |
| 12/27/2006 | EP0888290B1 Azulenyl nitrone spin trapping agents, methods of making and using same |
| 12/27/2006 | CN1886413A Phosphorylcholine group-containing compound and surface modifying agent composed of such compound |
| 12/27/2006 | CN1886411A Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same |
| 12/27/2006 | CN1886376A Pyridine compounds as inhibitors of dipeptidyl peptidase iv |
| 12/27/2006 | CN1884291A Di-2,4-dicumylphenyl pntaerythritol dphosphite preparation method |
| 12/27/2006 | CN1884290A Phosphorus-oxazoline ligand with spiro backbone and its uses in asymmetrical catalytic hydrogenation |
| 12/27/2006 | CN1884289A Di-2,4-dicumylphenyl pntaerythritol dphosphite preparation method |
| 12/27/2006 | CN1884288A Process for manufacturing monoalkyl phosphate ester |
| 12/27/2006 | CN1884287A Process for preparation of lecithin |
| 12/27/2006 | CN1884286A Process for preparing high-purity butoxy ethyl phosphate |
| 12/27/2006 | CN1291994C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 12/27/2006 | CN1291993C N-substituted benzothiazolyl-1-substituted phenyl-0,0-dialkyl-alpha-amino phosphonate ester derivatives, their preparation and application |
| 12/27/2006 | CN1291992C Preparation of N,N-di(2-ethoxyl) aminomethyl diethyl phosphoric acid |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/27/2006 | CN1291974C Process for preparation of carotenoids |
| 12/26/2006 | US7153974 Heat and corrosion resistance |
| 12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
| 12/26/2006 | US7153855 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 12/26/2006 | US7153843 Anticancer agents; antitumor agents |
| 12/26/2006 | US7153842 Phosphate esters of florfenicol that may be hydrolyzed to form free florfenicol, e.g., 1R,2S-1-(4-Methanesulfonylphenyl)-2-(2,2-dichloroacetylamino)-3-fluoropropyl]-di-tert-butyl phosphate |
| 12/26/2006 | US7153809 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 12/21/2006 | WO2006134603A1 Process for producing bisphosphonic acids and forms thereof |
| 12/21/2006 | WO2006133632A1 Nucleotide analogue prodrug and the preparation thereof |
| 12/21/2006 | WO2006100169A3 Unsymmetrically substituted phospholane catalysts |
| 12/21/2006 | WO2006080946A3 Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist |
| 12/21/2006 | WO2004022570A8 Preparation of solid ammonium glyphosate using organic solvent in extraction |
| 12/21/2006 | US20060287536 Phenyl-thiophene type vitamin d receptor modulators |
| 12/21/2006 | US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/21/2006 | US20060287281 Phosphohalohydrins, process for the production thereof and use thereof |
| 12/21/2006 | US20060287280 N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; zinc metallopeptidase inhibitors; promoting faster regeneration of bone mass after bone fractures, implantation of orthopedic and dental prostheses; osteogenesis stimulant; control phosphate metabolism |
| 12/21/2006 | US20060287274 Phosphoepoxides, method for making same and uses |
| 12/21/2006 | US20060287268 Splice-region antisense composition and method |
| 12/21/2006 | US20060287267 Controlling gene expression; viricides |
| 12/21/2006 | US20060287266 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 12/21/2006 | US20060287264 RNAi modulation of the BCR-ABL fusion gene and uses thereof |
| 12/21/2006 | US20060287250 Intermediates: omega(1-haloalkoxycarbonylamino)alkanoates, e.g., Benzyl 1-{[(1-Chloroethoxy)carbonyl]aminomethyl}-1-Cyclohexane Acetate |
| 12/21/2006 | US20060286632 Genetic engineered apolipoproteins has potent antioxidant activity on phospholipid surfaces; cardiovascular disorders, antiischemic agents, bone disorders, antiinflammatory agents |
| 12/21/2006 | DE10242017B4 Härter für Epoxidharze, dessen Verwendung und damit gehärtetes Epoxidharz Hardener for epoxy resins, its use and thus cured epoxy resin |
| 12/21/2006 | DE102004025071B4 Verfahren zur Herstellung von Diphenylazetidinon-Derivaten Process for the preparation of derivatives diphenylazetidinone |
| 12/20/2006 | EP1732938A1 Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors |
| 12/20/2006 | EP1732872A1 Method for hydroformylating olefins in the presence of organophosphoric compounds |
| 12/20/2006 | EP1527079B1 Alkoxyamines originating from beta-phosphorylated nitroxides and use thereof in radical polymerisation |
| 12/20/2006 | EP1468004B1 Metal complexes for use in metathesis |
| 12/20/2006 | EP1437999B1 Hydrolysis stable self-etching, self-priming adhesive |
| 12/20/2006 | CN1882600A Process for preparing bisphospholane ligands |
| 12/20/2006 | CN1882599A Process for recovering a crystalline product from solution |
| 12/20/2006 | CN1882598A Phosphinic acid derivatives |
| 12/20/2006 | CN1882327A Novel phosphorus-containing thyromimetics |
| 12/20/2006 | CN1880324A Method for the production of hydroxymethyl alkyl phosphinic acids and its ester thereof |
| 12/20/2006 | CN1880323A Novel strong acids, production method and uses thereof |
| 12/20/2006 | CN1290811C Liquid vegetable unsaturated alcohol and process for producing the same |
| 12/19/2006 | US7151195 Insecticidal effect even at smaller dosage; soil treatment shows an elevated absorption translocation action from roots for an excellent insecticidal effect; compounds with a N-(pentafluorosulfide-substituted phenyl)phthalamides of given formula |
| 12/19/2006 | US7151092 Cytarabine monophosphate prodrugs |
| 12/19/2006 | US7151070 Chiral catalyst, process for preparing the same and its use in the oxidate coupling of naphthols |
| 12/19/2006 | CA2168659C Substituted azaindolylidene compounds and process for their preparation |
| 12/19/2006 | CA2092493C N, n-bis(phosphonomethyl)-2-amino-1-propanol, derivatives and corresponding lower alkyl ethers and n-oxides thereof for high ph scale control |
| 12/14/2006 | WO2006132479A1 Sesamol derivatives or their salts, the process for preparing the same, and the skin external composition containing the same |
| 12/14/2006 | WO2006132107A1 Niobium 2-ethylhexanoate derivative, process for producing the derivative, organic acid metal salt composition containing the derivative, and process for producing thin film from the composition |
| 12/14/2006 | WO2006131616A1 New type of molecular junction between a semiconductor and a metal |
| 12/14/2006 | WO2006130994A1 Synthesis of glycerolipid carbamates and dicarbamates and their use as antitumor compounds |
| 12/14/2006 | WO2006110330A3 Novel metal hydroxide derivatives containing chemically bound organophosphorus or polyphosphate species as flame retardants |
| 12/14/2006 | US20060281936 Biofermented grain-based phytolipids and methods for isolating, modifying and using same |
| 12/14/2006 | US20060281715 Phosphates of secondary alcohols |
| 12/14/2006 | US20060281713 4-{2-[(R)-2-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-6-oxo-piperidin-1-yl]-ethylsulfanyl}-butyric acid or the alkyl ester; glaucoma, intraocular hypotensive agents |
| 12/14/2006 | US20060281711 2-Morpholin-4-yl-6-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or immune-mediated diabetes mellitus |
| 12/14/2006 | US20060281706 New phosphonate ester derivatives of drugs such as antivirals cidofovir, adefovir, tenofovir, azidothymidine (AZT), or bisphosphonates such as alendronate, or anticancers such as cytosine arabinoside; side effect reduction, less toxic; antiviral |
| 12/14/2006 | US20060281701 antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Filoviridae family, and in the treatment of a viral infection. The compounds and methods relate to the treatment of viral infections in mammals including primates by Ebola and Marburg viruses. |